公众号 / 文章呼吸衰竭与机械通气重症综合管理与镇静镇痛

47岁女性快速进展性低氧性呼吸衰竭

A 47-Year Old Woman With Rapidly Progressive Hypoxemic Respiratory Failure.
PubMed 文献 · Chest · 2021-01-01
一句话结论47岁女性两次快速进展低氧性呼吸衰竭,首次需VA-ECMO,CK 3000但自身抗体阴性,诊断不明。

一例47岁西班牙裔女性因2周咳嗽、咳白痰、活动后呼吸困难加重需增加吸氧就诊,伴乏力、盗汗、弥漫性肌痛和肢体无力。2年前曾因类似表现出现快速进展低氧性呼吸衰竭,影像示双肺浸润,经验性抗社区获得性肺炎治疗失败后插管,并发PEA心脏骤停、休克需多种升压药,因氧合困难转诊并启动VA-ECMO。支气管镜BAL病原学阴性,初始自身抗体(ANA、RF)阴性,CK升高至3000,后并发肝素诱导血小板减少症致左下肢缺血截肢。本次为再发,诊断仍不明确。

要点

  • 47岁女性,2周咳嗽咳白痰、活动后呼吸困难加重需增加吸氧,伴乏力、盗汗、弥漫性肌痛和肢体无力。
  • 2年前类似发作:双肺浸润经验性抗CAP治疗失败,仍进展为低氧性呼吸衰竭需插管。
  • 首次发作并发PEA心脏骤停后ROSC、休克需多种升压药,因氧合困难转诊启动VA-ECMO。
  • BAL细菌、病毒、真菌阴性,初始ANA和RF阴性,CK升高至3000,当时归因于截肢前骨筋膜室综合征。
  • 病程并发肝素诱导血小板减少症,致左下肢缺血需截肢;本次再发诊断仍不明。

适用人群与场景

  • 47岁西班牙裔女性,因咳嗽咳白痰、活动后呼吸困难加重需增加吸氧就诊于肺科门诊,伴乏力、盗汗、弥漫性肌痛和肢体无力。
  • 既往2年前有原因不明的快速进展性低氧性呼吸衰竭病史,当时因氧合困难转诊评估ECMO并启动VA-ECMO。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 首次发作:双肺浸润疑感染,经验性抗社区获得性肺炎治疗,但低氧性呼吸衰竭仍加重,抗生素扩大覆盖后仍需插管。
  • 因氧合困难转诊至中心评估ECMO,最终启动静脉-动脉体外膜氧合(VA-ECMO)。
  • 行支气管镜BAL检查细菌、病毒、真菌;初始自身免疫评估包括抗核抗体和类风湿因子。
  • 并发肝素诱导血小板减少症,致左下肢缺血需截肢。
  • 最终经支持治疗临床恢复,出院时予2 L补充氧,诊断为原因不明的急性呼吸衰竭。

红旗征与不能漏的情况

  • 快速进展性低氧性呼吸衰竭,经验性抗社区获得性肺炎治疗及抗生素扩大覆盖后仍恶化需插管。
  • 并发无脉性电活动心脏骤停后自主循环恢复,并出现休克需多种血管升压药。
  • 因氧合困难需转诊评估ECMO并启动VA-ECMO。
  • 肝素诱导血小板减少症致左下肢缺血需截肢。

研究设计与关键结果

  • 病例报告:47岁女性,2周咳嗽咳白痰、活动后呼吸困难加重需增加吸氧,伴乏力、盗汗、弥漫性肌痛和肢体无力;无咯血、发热、寒战、体重下降或皮疹。
  • 2年前首次发作:3周进行性呼吸困难和咳嗽,胸部CT示双肺浸润疑感染,经验性抗CAP治疗,抗生素扩大后仍出现低氧性呼吸衰竭需插管。
  • 首次病程并发PEA心脏骤停后ROSC、休克需多种升压药;因氧合困难转诊并启动VA-ECMO。
  • BAL细菌、病毒、真菌阴性;初始ANA和RF阴性,CK升高至3000;当时CK升高归因于截肢前骨筋膜室综合征。
  • 并发肝素诱导血小板减少症致左下肢缺血截肢;支持治疗后出院予2 L补充氧,诊断急性呼吸衰竭原因不明;本次再发。

证据类型、等级与局限

  • 病例报告(单例),无对照、无样本量、无统计比较;证据等级低,结果仅描述性,不能推断因果或推广。

对床旁实践的改变

  • 对快速进展低氧性呼吸衰竭且经验性抗感染治疗无效者,应尽早考虑非感染性病因并评估ECMO转诊(如原文因氧合困难转诊并启动VA-ECMO)。
  • 初始ANA和RF阴性不能排除自身免疫性疾病(原文首次发作时两者阴性但CK 3000)。
  • CK显著升高(原文3000)需鉴别骨筋膜室综合征等肌肉损伤原因,不能简单归因。
  • 使用肝素时需警惕肝素诱导血小板减少症及血栓/缺血并发症(原文致左下肢缺血截肢)。
  • 诊断不明时支持治疗可使部分患者恢复(原文出院予2 L补充氧),但需长期随访再发。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

A 47-year-old Hispanic woman presented to a pulmonology clinic with 2 weeks of cough productive of white sputum and worsening dyspnea on exertion, requiring increasing supplemental oxygen. In addition, she reported fatigue, night sweats, diffuse myalgias, and extremity weakness. She denied hemoptysis, fevers, chills, weight loss, or rash. Her medical history is significant for undifferentiated rapidly progressive hypoxemic respiratory failure 2 years before her current presentation. At that time, she presented to the ED with 3 weeks of progressive shortness of breath and cough. Chest CT imaging showed bilateral infiltrates concerning for infection, and she was treated empirically for community-acquired pneumonia. She developed worsening hypoxemic respiratory failure despite broadening of her antibiotics and subsequently required intubation. Her course was further complicated by pulseless electrical activity arrest with return of spontaneous circulation and development of shock requiring multiple vasopressors. Because of difficulty with oxygenation, she was referred to our center for extracorporeal membrane oxygenation evaluation and was ultimately started on venous-arterial extracorporeal membrane oxygenation. Bronchoscopy with BAL was negative for bacterial, viral, and fungal origins, and initial autoimmune evaluation (antinuclear antibody and rheumatoid factor) was negative, except an elevated creatine kinase (CK) to 3,000. Her course was complicated by heparin-induced thrombocytopenia, and as a result she suffered limb ischemia requiring amputation of her left lower extremity. Elevated CK at that time was attributed to compartment syndrome before amputation. The patient recovered clinically with supportive care and was ultimately discharged on 2 L supplemental oxygen, with a diagnosis of acute respiratory failure of unclear origin. The patient had stability in her clinical symptoms until this current presentation.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Fox SC, Trivedi AP. A 47-Year Old Woman With Rapidly Progressive Hypoxemic Respiratory Failure. Chest. 2021. PMID: 33563457. doi:10.1016/j.chest.2020.08.2119

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。